Increased levels of oxidatively damaged DNA induced by chromium(III) and H2O2: Protection by melatonin and related molecules

Journal of Pineal Research

Volumn 29, Issue 1, 2000, Pages 54-61

  Qi, Wenbo ^a   Reiter, Russel J ^a   Tan, Dun Xian ^a   Manchester, Lucien C ^a   Siu, Andrew W ^a   Garcia, Joaquin J ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

6 Hydroxymelatonin; 8 Hydroxydeoxyguanosine; Chromium; Indole 3 propionic acid; Melatonin; N acetylserotonin; Pinoline

Indexed keywords

6 HYDROXYMELATONIN; 8 HYDROXYDEOXYGUANOSINE; CHROMIUM; HYDROGEN PEROXIDE; MELATONIN; N ACETYLSEROTONIN; PROPIONIC ACID DERIVATIVE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CATTLE; CHEMICAL ANALYSIS; DNA DAMAGE; HORMONE ACTION; INHIBITION KINETICS; NONHUMAN; OXIDATION; THYMUS;

EID: 0033949540     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-079X.2000.290108.x     Document Type: Article

References (63)

1. AIYAR, J., H.J. BERKOVITS, R.A. FLOYD, K.E. WETTERHAHN (1991) Reaction of chromium(VI) with glutathione or with hydrogen peroxide: Identification of reactive intermediates and their role in chromium(VI)-induced DNA damage. Environ. Health Perspect. 92:53-62.
2. ANDERSON, R.A. (1990) Nutritional role of chromium in glucose and lipid metabolism of humans. In: Metal Ions in Biology and Medicine, P. Collery, ed. John Libbey, London, pp. 95-99.
3. ANTTILA, S. (1990) Biological effects of occupational and environmental exposure to chromium. In: Metal Ions in Biology and Medicine, P. Collery, ed. John Libbey, London, pp. 315-319.
4. BIANCHI, V., L. CELOTTI, G. LANFRANCHI, F. MAJONE, G. MARIN, A. MONTALDI, G. SPONZA, G. TAMINO, P. VENIER, A. ZANTEDESCHI, A.G. LEVIS (1983) Genetic effects of chromium compounds. Mutat. Res. 117:279-300.
5. CHAN, T. Y., P.L. TANG (1996) Characterization of the antioxidant effects of melatonin and related indoleamines in vitro. J. Pineal Res. 20:187-191.
6. CHENG, K.C., D.S. CAHILL, H. KASAI, S. NISHIMURA, L.A. LOEB (1992) 8-hydroxydeoxyguanosine, an abundant form of oxidative DNA damage, causes G→T and A→C substitutions. J. Biol. Chem. 267:166-172.
7. CHYAN, Y.-J., B. POEGGELER, R.A. OMAR, D.G. CHAIN, B. FRANGINO, J. GHISO, M.A. PAPPOLLA (1999) Potent neuro-protective properties against the Alzheimer β-amyloid by endogenous melatonin-related indole structure, indole-3-propionic acid. J. Biol. Chem. 274:21937-21942.
8. CONNETT, P.H., K.E. WETTERHAHN (1983) Metabolism of the carcinogen chromate by cellular constituents. Struct. Bonding 54:93-124.
9. COSTA, E.J.X., R.H. LOPES, M.T. LAMY-FREUND (1994) Permeability of pure lipid bilayers to melatonin. J. Pineal Res. 16:123-126.
10. COTO-MONTES, A., R. HARDELAND (1999) Antioxidant effects of melatonin in Drosophila melanogaster: Antagonization of damage induced by the inhibition of catalase. J. Pineal Res. 27:154-158.
11. DANIELSSON B.R.G., E. HASSOUN, L. DENCKER (1982) Embryo toxicity of chromium: Distribution in pregnant mice and effects on embryonic cells in vitro. Arch. Toxicol. 51:233-245.
12. DE FLORA, S., K.E. WETTERHAHN (1989) Mechanisms of chromium metabolism and genotoxicity. Life Chem. Rep. 7:168-244.
13. DE FLORA, S., M. BANASCO, D. SERRA, P. ZANACCHI (1990) Genotoxicity of chromium compounds: A review. Mutat. Res. 238:99-112.
14. FINNOCCHIARO, L.M.E., G.C. GLIKIN (1998) Intracellular melatonin distribution in cultured cell lines. J. Pineal Res. 24:22-34.
15. HARA, M., M. IIGO, R. OHTANI-KANEKO, N. NAKAMURA, T. SUZUKI, R.J. REITER, K. HIRATA (1996) Administration of melatonin and related indoles prevents exercise-induced cellular oxidative changes in rats. Biol. Signals 6:90-100.
16. HNEIHEN, A.S., A.M. STANDEVEN, K.E. WETTERHAHN (1993) Differential binding of chromium(VI) and chromium(III) complexes to salmon sperm nuclei and nuclear DNA and isolated calf thymus DNA. Carcinogenesis 14:1795-1803.
17. LANGARD, S. (1988) Chromium carcinogenicity: A review of experimental animal data. Sci. Total Environ. 71:341-350.
18. LANGARD, S. (1990) One hundred years of chromium and cancer: A review of epidemiological evidence and selected case reports. Am. J. Ind. Med. 17:189-215.
19. 3H]imipramine recognition site. Eur. J. Pharmacol. 102:379-380.
20. LEONARD, A., R.R. LAWERYS (1980) Carcinogenicity and mutagenicity of chromium. Mutat. Res. 76:227-239.
21. LEZOUALC'H, F., M. SPARAPANI, C. BEHL (1998) N-acetylserotonin and melatonin protect neurons against oxidative challenges and suppress the activity of the transcription factor NF-kappaB. J. Pineal Res. 24:168-178.
22. LI, X.J., L.M. ZHANG, J. GU, A.Z. ZHANG, F.Y. SUN (1997) Melatonin decreases production of hydroxyl radical during ischemia-reperfusion. Acta Pharmacol. Sinica 18:394-396.
23. LLOYD, D.R., P.L. CARMICHAEL, D.H. PHILLIPS (1998) Comparison of the formation of 8-hydroxy-2-deoxyguanosione and single-and double-strand breaks in DNA mediated by Fenton reaction. Chem. Res. Toxicol. 11:420-427.
24. LONGONI, B., W.A. PRYOR, P. MARCHIAFAVA (1997) Inhibition of lipid peroxidation by N-acetylserotonin and its role in retinal physiology. Biochem. Biophys. Res. Commun. 233:778-780.
25. LU, Y.-Y., J.-L. YANG (1995) Long-term exposure to chromium(VI) oxide leads to defects in sulfate transport system in Chinese hamster ovary cells. J. Cell. Biochem. 57:655-665.
26. MANNING, F.C.R., L.J. BLANKENSHIP, J.P. WISE, J. XIU, L.C. BRIDGEWATER, S.R. PATIERNO (1994) Induction of internucleosomal DNA fragmentation by carcinogenic chromate: Relationship to DNA damage, genotoxitity and inhibition of macromolecular synthesis. Environ. Health Perspect. 102:159-167.
27. MATUSZAK, Z., K.J. RESZKA, C.F. CHIGNELL (1997) Reaction of melatonin and related indoles with hydroxyl radical: EPR and spin trapping investigation. Free Radic. Biol. Med. 23:367-372.
28. MENENDEZ-PELAEZ, A., B. POEGGELER, R.J. REITER, L. BARLOW-WALDEN, M.I. PABLOS, D.X. TAN (1993) Nuclear localization of melatonin in different mammalian tissues: Immunocytochemical and radioimmunoassay evidence. J. Cell. Biochem. 53:373-382.
29. NORSETH, T. (1986) The carcinogenicity of chromium and its salts. Br. J. Int. Med. 43:649-651.
30. PÄHKLA, R., M. ZILMER, T. KULLISA, L. RAGO (1998) Comparison of antioxidant activity of melatonin and pinoline in vitro. J. Pineal Res. 24:96-101.
31. PIERI, C., F. MORONI, M. MARRA, R. RECCHIONI, F. MARCHESELLI (1994) Melatonin: A peroxyl radical scavenger more effective than vitamin E. Life Sci. 55:271-276.
32. PIERREFICHE, G., G. TOPALL, G. COURBOIN, I. HENRIT, H. LABORIT (1993) Antioxidant activity of melatonin in mice. Res. Commun. Chem. Pathol. Pharmacol. 80:211-223.
33. PLESS, G., T.J. FREDERIKSEN, J.J. GARCIA, R.J. REITER (1999) Pharmacological aspects of N-acetyl-5-methoxytraptamine (melatonin) and 6-methoxy-1,2,3,4-tetrahydro-(-carboline (pinoline) as antioxidants: Reduction of oxidative damage in brain region homogenates. J. Pineal Res. 26:236-246.
34. POEGGELER, B., M.A. PAPPOLLA, R. HARDELAND, A. RASSOULPOUR, P.S. HODGKINS, P. GUIDETTI, R. SCHWARCH. (1999) Indole-3-propionate: A potent hydroxyl radical scavenger in rat brain. Brain Res. 815:382-388.
35. QI, W., R.J. REITER, D.X. TAN, L.C. MANCHESTER, S.J. KIM, J.J. GARCIA (1999) Inhibitory effects of melatonin on ferric nitrilotriacetate-induced lipid peroxidation and oxidative DNA damage in rat kidney. Toxicology (in press).
36. REITER, R.J. (1991) Pineal melatonin: Cell biology of its synthesis and of its physiological interactions. Endocr. Rev. 12:151-158.
37. REITER, R.J., D. MELCHIORRI, E. SEWERYNEK, B. POEGGELER, L. BARLOW-WALDEN, J.I. CHUANG, G.G. ORTIZ, D.A. ACUNA-CASTROVIEJO (1995) A review of the evidence supporting melatonin's role as an antioxidant. J. Pineal Res. 18:1-11.
38. REITER, R.J., L. TANG, J.J. GARCIA, A. MUNOZ-HOYOS (1997) Pharmacological actions of melatonin in oxygen radical pathophysiology. Life Sci. 60:2255-2271.
39. REITER, R.J., D.X. TAN, W. QI (1998a) Suppression of oxygen toxicity by melatonin. Acta Pharmacol. Sinica 19:575-581.
40. REITER, R.J., D.X. TAN, S.J. KIM, W. QI (1998b) Melatonin as a pharmacological agent against oxidative damage to lipids and DNA. Proc. West. Pharmacol. Soc. 41:229-236.
41. ROMERO, P., C. OSUNA, A. GARCIA-PERGANEDA, A. CARRILLO-VICO, J.M. GUERRERO (1999) The pineal secretory product melatonin reduces hydrogen peroxide-induced DNA damage in U-937 cells. J. Pineal Res. 26:227-235.
42. SEN, P., M. COSTA (1986) Incidence and localization of sister chromatid exchanges induced by nickel and chromium compounds. Carcinogenesis 7:1527-1533.
43. SEWERYNEK, E., G.G. ORTIZ, R.J. REITER, M.I. PABLOS, D. MELCHIORRI, W.M.U. DANIELS (1996) Lipopolysaccharide-induced DNA damage is greatly reduced in rats treated with the pineal hormone melatonin. Mol. Cell. Endocrinol. 117:183-188.
44. SHIBUTAI, S., M. TAKESHITA, A.P. GROLLMAN (1991) Insertion of specific base during DNA synthesis past the oxidation-damaged base 8-oxodG. Nature 349:431-434.
45. SHIDA, C.S., A.M.L. CASTRUCCI, M.T. LAMY-FREUND (1994) High melatonin solubility in aqueous medium. J. Pineal Res. 16:198-201.
46. SINGH, J., D.L. CARLISLE, D.E. PRITCHARD, S.R. PATERNO (1998) Chromium-induced genotoxity and apoptosis: Relationship to chromium carcinogenesis. Oncol. Rep. 5:1307-1318.
47. SNOW, E.T. (1991) A possible role for chromium(III) in genotoxicity. Environ. Health Perspect. 92:75-81.
48. STASICA, A.P., P. ULANSKI, J.M. ROSIAK (1998) Melatonin as a hydroxyl radical scavenger. J. Pineal Res. 25:65-66.
49. SUGIYAMA, M. (1992) Role of physiological antioxidants in chromium(VI)-induced cellular injury. Free Radic. Biol. Med. 12:397-407.
50. TAN, D.-X., L.-D. CHEN, B. POEGGELER, L.C. MANCHESTER, R.J. REITER (1993) Melatonin: A potent, endogenous hydroxyl radical scavenger. Endocrine J. 1:57-60.
51. TAN, D.-X., R.J. REITER, L.-D. CHEN, B. POEGGELER, L.C. MANCHESTER, L. BARLOW-WALDEN (1994) Both physiological and pharmacological levels of melatonin reduce DNA adduct formation induced by the carcinogen safrole. Carcinogenesis 15:215-218.
52. TANG, L., R.J. REITER, Z.-R. LI, G.G. ORTIZ, B.P. YU, J.J. GARCIA (1998) Melatonin reduces the increase in 8-hydroxydeoxyguanosine levels in the brain and liver of kainic acid-treated rats. Mol. Cell Biochem. 178:299-303.
53. TSAPAKOS, M.J., K.E. WETTERHAHN (1983) The interaction of chromium with nucleic acid. Chem.-Biol. Interactions 46:265-277.
54. TSOU, T.-C., C.-L. CHEN, T.-Y. LIU, J.-L. YANG (1996) Induction of 8-hydroxydeoxyguanosione in DNA by chromium(III) plus hydrogen peroxide and its prevention by scavengers. Carcinogenesis 17:103-108.
55. TSUDA, H., K. KATO (1977) Chromosomal aberrations and morphological transformation in hamster embryonic cells treated with potassium dichromate in vitro. Mutat. Res. 46:87-94.
56. VERSCHOOR, M.A., P.C. BRAGET, R.F.M. HERBER, R.L. ZIELHUIS, W.C.M. ZWENNIS. (1988) Renal function of chrom-plating workers and welders. Int. Arch. Occup. Environ. Health 60:67-70.
57. VIJAYALAXMI, M.L. MELTZ, R.J. REITER, T.S. HERMAN (1999) Melatonin and protection from genetic damage in blood and bone marrow: Whole-body radiation studies in mice. J. Pineal Res. 27: 221-225.
58. WAKATSUKI, A., Y. OKATANI, C. IZUMIYA, N. IKENOUE (1999) Melatonin protects against ischemia and repurfusion-induced oxidative lipid and DNA damage in fetal rat brain. J. Pineal Res. 26:147-152.
59. WOLF, T.H., R. KASEMANN, H. OTTENWALDER (1989) Molecular interaction of different chromium species with nucleotide and nucleic acids. Carcinogenesis 10:655-659.
60. WOLFLER, A., P.M. ABUJA, K. SCHAUENSTEIN, P.M. LIEBMANN (1999) N-acetylserotonin is better extra-and intracellular antioxidant than melatonin. FEBS Lett. 449:206-210.
61. YANG, J.L., Y.-C. HSIEH, C.-W. WU, T.-C. LEE (1992) Mutational specificity of chromium(VI) compounds in the hprt locus of Chinese hamster ovary-K1 cells. Carcinogenesis 13:2053-2057.
62. YOUNG, S., G.M. ANDERSON, S. GUTHIER, W.C. PURDY (1980) The origin of indoleacetic acid and indolepropionic acid in rat and human cerebrospinal fluid. J. Neurochem. 34:1087-1092.
63. ZANG, L.Y., G. COSMA, H. GARDNER, V. VALLYNATHAN (1998) Scavenging of reactive oxygen species by melatonin. Biochem. Biophys. Acta 1425:469-477.